
Specialty pharma company Knight Therapeutics nets $70mm in bought deal
Executive Summary
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- OTC, Consumer
- Specialty Pharmaceuticals
-
Biotechnology
-
Drug Discovery Tools
-
Molecular Diversity
- Natural Products
-
Molecular Diversity
-
Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Financing
- FOPO
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com